Skip to content

Analysis of the factors affecting outcome for oncology patients admitted to the Intensive Care Unit (ICU) during the course of their treatment at Launceston General Hospital, Tasmania.

Analysis of the factors affecting outcome for oncology patients admitted to ICU during the course of their treatment at Launceston General Hospital, Tasmania.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12613000830796
Acronym
ICU ONCOLOGY
Enrollment
537
Registered
2013-07-29
Start date
2013-01-10
Completion date
2013-12-31
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Oncology and Haematology patients are at increased risk to be admitted to the ICU during the course of their treatment, especially when they present with an advanced or aggressive disease. Unfortunately there is high mortality rate among this cohort of patients. There are many factors that may play a crucial role such as presence of organ failure, intubation status, oxygen saturation and compromise to the cardiovascular system. It is important to study all these factors as well as other factors such as underlying disease and disease status in order to predict patient outcome. There are paucity of data in this regard and therefore it highlights the importance of this audit in our hospital.

Interventions

This study will investigate all patients with cancer who were admitted to the Intensive Care Unit at the Launceston General Hospital between 2006 and 2012. The data from this trial will help to assess factors that may determine the survival of oncology patients who require an admission to the ICU during the course of their treatment. To document treatment modalities or any other related data for these patients in correlation to outcome. To record any complications secondary to the admission t

This study will investigate all patients with cancer who were admitted to the Intensive Care Unit at the Launceston General Hospital between 2006 and 2012. The data from this trial will help to assess factors that may determine the survival of oncology patients who require an admission to the ICU during the course of their treatment. To document treatment modalities or any other related data for these patients in correlation to outcome. To record any complications secondary to the admission to the ICU for future references.

Sponsors

Launceston General Hospital
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
No

Inclusion criteria

Any oncology patient who has been admitted to ICU at the Launceston General Hospital, Tasmania (LGH) during the course of their treatment or diagnosis of their cancer

Exclusion criteria

No exclusion criteria

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026